A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients

This study has been completed.

Study NCT00085826 Information provided by Astellas Pharma Inc

First Received: June 15, 2004 Last Updated: October 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2004
Estimated Primary Completion Date:	No date given